Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions

• Published in: BMC cancer Vol. 18; no. 1; pp. 112 - 9
• Main Authors: Paz-Zulueta, María, Álvarez-Paredes, Ledicia, Rodríguez Díaz, Juan Carlos, Parás-Bravo, Paula, Andrada Becerra, Ma. Encarnación, Rodríguez Ingelmo, José María, Ruiz García, María Montserrat, Portilla, Joaquín, Santibañez, Miguel
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 30.01.2018; BioMed Central; BMC
• Subjects: Adult; Female; Genotype; Health aspects; Human papillomavirus 16 - genetics; Human papillomavirus 16 - pathogenicity; Human papillomavirus 18 - genetics; Human papillomavirus 18 - pathogenicity; Humans; Infection; Middle Aged; Papillomavirus infections; Papillomavirus Infections - genetics; Papillomavirus Infections - pathology; Papillomavirus Infections - prevention & control; Papillomavirus Infections - virology; Papillomavirus Vaccines - administration & dosage; Prevention; Risk factors; Spain - epidemiology; Uterine Cervical Neoplasms - genetics; Uterine Cervical Neoplasms - pathology; Uterine Cervical Neoplasms - prevention & control; Uterine Cervical Neoplasms - virology; Vaccination; Vaccination Coverage; Vaginal Smears

The new nine-valent vaccine against human papillomavirus (HPV) includes the four HPV genotypes (6, 11, 16, and 18) that are targeted by the older quadrivalent HPV vaccine, plus five additional oncogenic types (31, 33, 45, 52, and 58) remain significantly associated with high grade lesions. We aimed...